Prudential PLC Sarepta Therapeutics, Inc. Transaction History

Prudential PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $875,525 - $2.05 Million	-12,118 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$125.56 - $178.74 $36,286 - $51,655	-289 Reduced 2.33%	12,118 $2.07 Million
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $154,577 - $209,565	-1,216 Reduced 8.93%	12,407 $1.74 Million
Q2 2020 Jul 31, 2020	BUY	$93.0 - $171.7 $1.27 Million - $2.34 Million	13,623 New	13,623 $2.18 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.71B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.